PDCD1 and melanoma: Although antigen-loaded EVs promoted the immunogenicity of B16 melanoma and immune cell infiltration in this model, we did not observe an improved response to EVs and anti–PD-1/anti–PD-L1 combination treatment on survival in the treatment model compared with EVs alone.